Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 4, 2022

View Archived Issues

Deep immunophenotyping study characterizes advanced immune aging in individuals with Down syndrome

Co-stimulation with CD81 promotes CAR T-cell transduction toward naive T cells

Meta-analysis reveals candidate variants associated with brain traits

Researchers present preclinical model of ALS

New T-type calcium channel blockers identified at Sumitomo Dainippon Pharma

University of Tokyo discloses BDNF/NT-3 growth factor receptor activators

Enanta Pharmaceuticals presents compounds for influenza, RSV infections

Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors

New plasma kallikrein inhibitors identified at Merck Sharp & Dohme

Novel preclinical models of invasive papillary cholangiocarcinoma

Study links mycobiome, IL-33, tumor growth in pancreatic cancer

LISCure and Scripps collaborate on bacteria-mediated immuno-oncology candidates for cancer

Researchers present single-cell atlas of the normal and malformed brain vasculature

Novel AH:CpG-adjuvanted RBD vaccine with promising efficacy in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.